Evidence map›Paper›PMID 28989676›Full record

ArticleChemical science2017

Rapid determination of medulloblastoma subgroup affiliation with mass spectrometry using a handheld picosecond infrared laser desorption probe.

Michael Woolman, Isabelle Ferry, Claudia M Kuzan-Fischer, Megan Wu, Jing Zou, Taira Kiyota, Semra Isik, Delaram Dara, Ahmed Aman, Sunit Das and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Michael WoolmanTechna Institute for the Advancement of Technology for Health , University Health Network , 100 College Street , Toronto , ON M5G 1P5 , Canada . Email: arash.zarrine.afsar@utoronto.ca.
Isabelle FerryPeter Gilgan Centre for Research and Learning , Hospital for Sick Children , 686 Bay Street , Toronto , ON M5G 0A4 , Canada.
Claudia M Kuzan-FischerPeter Gilgan Centre for Research and Learning , Hospital for Sick Children , 686 Bay Street , Toronto , ON M5G 0A4 , Canada.
Megan WuPeter Gilgan Centre for Research and Learning , Hospital for Sick Children , 686 Bay Street , Toronto , ON M5G 0A4 , Canada.
Jing ZouTechna Institute for the Advancement of Technology for Health , University Health Network , 100 College Street , Toronto , ON M5G 1P5 , Canada . Email: arash.zarrine.afsar@utoronto.ca.
Taira KiyotaDrug Discovery Program , Ontario Institute for Cancer Research , 661 University Avenue , Toronto , ON M5G 0A3 , Canada.
Semra IsikPeter Gilgan Centre for Research and Learning , Hospital for Sick Children , 686 Bay Street , Toronto , ON M5G 0A4 , Canada.
Delaram DaraTechna Institute for the Advancement of Technology for Health , University Health Network , 100 College Street , Toronto , ON M5G 1P5 , Canada . Email: arash.zarrine.afsar@utoronto.ca.
Ahmed AmanDrug Discovery Program , Ontario Institute for Cancer Research , 661 University Avenue , Toronto , ON M5G 0A3 , Canada.
Sunit DasPeter Gilgan Centre for Research and Learning , Hospital for Sick Children , 686 Bay Street , Toronto , ON M5G 0A4 , Canada.
Michael D TaylorPeter Gilgan Centre for Research and Learning , Hospital for Sick Children , 686 Bay Street , Toronto , ON M5G 0A4 , Canada.
James T RutkaPeter Gilgan Centre for Research and Learning , Hospital for Sick Children , 686 Bay Street , Toronto , ON M5G 0A4 , Canada.
Howard J GinsbergTechna Institute for the Advancement of Technology for Health , University Health Network , 100 College Street , Toronto , ON M5G 1P5 , Canada . Email: arash.zarrine.afsar@utoronto.ca.
Arash Zarrine-AfsarTechna Institute for the Advancement of Technology for Health , University Health Network , 100 College Street , Toronto , ON M5G 1P5 , Canada . Email: arash.zarrine.afsar@utoronto.ca.ORCID 0000-0002-8013-6893
Toronto Public Health · CASt. Michael's Hospital · CAUniversity Health Network · CAOntario Institute for Cancer Research · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medulloblastoma (MB), the most prevalent malignant childhood brain tumour, consists of at least 4 distinct subgroups each of which possesses a unique survival rate and response to treatment. To rapidly determine MB subgroup affiliation in a manner that would be actionable during surgery, we subjected murine xenograft tumours of two MB subgroups (SHH and Group 3) to Mass Spectrometry (MS) profiling using a handheld Picosecond InfraRed Laser (PIRL) desorption probe and interface developed by our group. This platform provides real time MS profiles of tissue based on laser desorbed lipids and small molecules with only 5-10 seconds of sampling. PIRL-MS analysis of

Identifiers

PMID28989676
PMCPMC5628578
OpenAlexW2739277344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.